FDA NDC Directory · JSON-LD · Markdown

FLUCYTOSINE

NDC 59651-331 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA213665
Dosage form / routeCAPSULE · ORAL
Active ingredientsFLUCYTOSINE (250 mg/1)
Marketing started20200501
Package count1

External sources

Source: openFDA. Public-domain (CC0).